Found: 21
Select item for more details and to access through your institution.
Correctly understanding the diabetes data in FOURIER.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2342, doi. 10.1111/dom.13812
- By:
- Publication type:
- Article
A 24‐week, randomized, double‐blind, active‐controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2248, doi. 10.1111/dom.13801
- By:
- Publication type:
- Article
Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2333, doi. 10.1111/dom.13810
- By:
- Publication type:
- Article
Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2257, doi. 10.1111/dom.13802
- By:
- Publication type:
- Article
Commentary: SGLT inhibitors in type 1 diabetes: Place in therapy and a risk mitigation strategy for preventing diabetic ketoacidosis ‐ the STOP DKA protocol.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2189, doi. 10.1111/dom.13836
- By:
- Publication type:
- Article
Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2315, doi. 10.1111/dom.13816
- By:
- Publication type:
- Article
Response to Umpierrez et al.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2344, doi. 10.1111/dom.13815
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter inhibitors: Medications that mimic fasting for cardiovascular prevention.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2211, doi. 10.1111/dom.13814
- By:
- Publication type:
- Article
Impact of intentional weight loss on diabetic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2338, doi. 10.1111/dom.13813
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2192, doi. 10.1111/dom.13811
- By:
- Publication type:
- Article
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2305, doi. 10.1111/dom.13809
- By:
- Publication type:
- Article
Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2294, doi. 10.1111/dom.13808
- By:
- Publication type:
- Article
Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double‐blind, phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2284, doi. 10.1111/dom.13807
- By:
- Publication type:
- Article
Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2327, doi. 10.1111/dom.13806
- By:
- Publication type:
- Article
Do GLP‐1RAs and SGLT‐2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2274, doi. 10.1111/dom.13805
- By:
- Publication type:
- Article
Investigating optimal β‐cell‐preserving treatment in latent autoimmune diabetes in adults: Results from a 21‐month randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2219, doi. 10.1111/dom.13797
- By:
- Publication type:
- Article
Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2203, doi. 10.1111/dom.13804
- By:
- Publication type:
- Article
No significant association of type 2 diabetes‐related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2267, doi. 10.1111/dom.13803
- By:
- Publication type:
- Article
A pre‐specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2240, doi. 10.1111/dom.13800
- By:
- Publication type:
- Article
SCO‐792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2228, doi. 10.1111/dom.13799
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2187, doi. 10.1111/dom.13434
- Publication type:
- Article